Michelle’s abstract titled “Creating a Transgenic Mouse Model to Study the Role of FGF21 in Insulin-Mediated Pseudoacromegaly” has been selected for an oral presentation at the Pediatric Endocrine Society meeting on April 28-May 1. Congrats Michelle!